Friday 6 November 2026 Export TXG’s income statement to Excel — free account

10x Genomics

TXG Healthcare Medical Devices

10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024.

Revenue: +1.12%
EPS: +31.8%
Free cash flow: −4.61%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

59.18 1.12 +1.93%

Follow TXG

Alert me

Market cap: $7.6B
P/E: 0.0×
Fwd P/E: −95.9×
Dividend yield: —
F-score: 6/9
Altman Z: 3.99
Beneish M: −3.23
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26 From the 10-Q filed 6 Nov	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	6	5	6	6	+8 more TTM periods Free account
ROE Full definition →	(8.27%)	(9.40%)	(2.98%)	(5.78%)
ROA Full definition →	(6.42%)	(7.47%)	(2.36%)	(4.44%)
ROIC Full definition →	(17.20%)	(20.20%)	(8.81%)	(13.97%)
Return on Tangible Assets Full definition →	(8.51%)	(9.74%)	(2.92%)	(5.75%)
Average Days of Receivables Full definition →	0.00	29.96	32.08	46.84
Free Cash Flow per Share Full definition →	0.72	0.93	0.95	1.04
Free Cash Flow Full definition →	93.77	121.44	122.18	130.12
Capital Expenditures Full definition →	(5.93)	(5.65)	(5.64)	(5.93)
Other line items
Cash ROIC Full definition →	6.63%	8.82%	9.02%	9.86%
Accounts Receivable Turnover Full definition →	0.00	7.27	11.75	7.52
Accounts Payable Turnover Full definition →	8.77	10.09	14.13	15.52
Inventory Turnover Full definition →	2.75	3.04	3.03	2.85
Average Days of Payables Full definition →	45.32	40.85	32.76	23.36
Days of Inventory on Hand Full definition →	135.63	103.88	100.55	103.37
Tax Rate Full definition →	0.03	0.00	0.18	0.09
Research and Development Expense of Revenue Full definition →	35.98%	36.76%	36.20%	37.12%
Selling, General and Administrative Expense of Revenue Full definition →	48.13%	48.14%	45.83%	49.18%
Share Based Compensation of Revenue Full definition →	15.61%	16.01%	15.76%	16.97%
Operating CF/Net income Full definition →	(1.49)	(1.69)	(5.64)	(3.12)
Depreciation/Fixed assets Full definition →	0.00	0.22	0.21	0.19
Capex/Depreciation Full definition →	0.00	(0.12)	(0.12)	(0.14)
Revenue per Share Full definition →	4.73	4.75	4.98	5.15
Operating CF per Share Full definition →	0.76	0.98	1.00	1.09
Capex per Share Full definition →	(0.05)	(0.04)	(0.04)	(0.05)
Capex to Sales Full definition →	0.01	0.01	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly